IMMUNOTHERAPY IN HEAD AND NECK CANCER: ADVANCES IN IMMUNE CHECKPOINT INHIBITION AND TARGETED IMMUNOTHERAPIES FOR ENHANCED TREATMENT OUTCOMES. (2024). Medical Insights, 2(02), 11-20. https://medicalinsights.online/index.php/journal/article/view/26